Women's Health

Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
GoInPharma
Teva Pharmaceutical
M&A
Respiratory
Women's Health
oncology
Medis
Flag link:
Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets
Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets
Motley Fool
Teva Pharmaceutical
M&A
Women's Health
oncology
Flag link:
Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block
Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block
Fierce Pharma
Teva Pharmaceutical
Pharma CEOs
M&A
Women's Health
oncology
Flag link:
3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April
3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April
Fierce Pharma
Teva Pharmaceutical
bribery
Women's Health
oncology
reorganization
Flag link:
Debt-laden Teva, looking for cash, weighs $2B women's health sale: report
Debt-laden Teva, looking for cash, weighs $2B women's health sale: report
Fierce Pharma
Teva Pharmaceutical
M&A
Women's Health
Flag link:
Birth Control Can Protect Women From Certain Cancers For Decades
Birth Control Can Protect Women From Certain Cancers For Decades
Forbes
birth control pill
contraceptives
Women's Health
Flag link:
FDA touts own role in women's heart health
FDA touts own role in women's heart health
BioPharma Dive
FDA
Women's Health
heart disease
Flag link:
AMAG to hire 150 new sales reps to tout newly licensed women's health med Intarosa
AMAG to hire 150 new sales reps to tout newly licensed women's health med Intarosa
Fierce Pharma
Amag Pharmaceuticals
Women's Health
hirings
drug reps
Intarosa
vaginal pain
Flag link:
Women’s health biotech ObsEva sets terms for $87M IPO
Women’s health biotech ObsEva sets terms for $87M IPO
Fierce Biotech
IPOs
ObsEva
Women's Health
Flag link:
Drugmakers revive R&D focus on long stagnant women's health market
Drugmakers revive R&D focus on long stagnant women's health market
Medical Marketing and Media
R&D
Women's Health
innovation
Myovant Sciences
Amgen
UCB Pharma
breast cancer
Pfizer
S1 Biopharma
Ibrance
Addyi
Flag link:
Babyscripts Aims To Revolutionize Prenatal Care In The U.S.
Babyscripts Aims To Revolutionize Prenatal Care In The U.S.
Forbes
Babyscripts
devices
prenatal care
Women's Health
Flag link:
Why Medtronic Acquired Smith & Nephew’s Gynecology Business
Why Medtronic Acquired Smith & Nephew’s Gynecology Business
Yahoo/Market Realist
Medtronic
Smith & Nephew
Women's Health
M&A
Flag link:
Smith & Nephew to sell gynaecology unit to Medtronic
Smith & Nephew to sell gynaecology unit to Medtronic
Yahoo/Reuters
Smith & Nephew
M&A
Medtronic
devices
Women's Health
Flag link:
AbbVie’s Therapies in Virology, Neurology, and Women’s Health
AbbVie’s Therapies in Virology, Neurology, and Women’s Health
Yahoo/Market Realist
AbbVie
virology
neurology
Women's Health
Flag link:
Endo shutting down its women's health division
Endo shutting down its women's health division
Bizjournals.com
Endo International
Women's Health
Astora
Flag link:
AstraZeneca Spins Out Women's Health Treatment to $62M Startup, Millendo
AstraZeneca Spins Out Women's Health Treatment to $62M Startup, Millendo
Forbes
AstraZeneca
Women's Health
Millendo Therapeutics
PCOS
R&D
Flag link:
Mylan's women's health biz leaps to fore in emerging markets with $750M Famy purchase
Mylan's women's health biz leaps to fore in emerging markets with $750M Famy purchase
Fierce Pharma
Mylan Labs
Women's Health
Famy
India
M&A
Flag link:
Teva Stops R&D In Other Therapeutic Areas, Including Oncology And Women's Health
Teva Stops R&D In Other Therapeutic Areas, Including Oncology And Women's Health
NASDAQ.com
Teva Pharmaceutical
R&D
oncology
Women's Health
Flag link:
Amag Pharma buys women's health company Lumara for $675 mln
Amag Pharma buys women's health company Lumara for $675 mln
Yahoo/Reuters
Amag Pharmaceuticals
M&A
Lumara
Women's Health
Flag link:
Women's health: Boston Scientific nabs the rest of IoGyn for $65M
Women's health: Boston Scientific nabs the rest of IoGyn for $65M
Mass Device
Boston Scientific
devices
IoGyn
Women's Health
Flag link:

Pages